Jubilant Ingrevia Limited completed acquisition of 100% equity stake in Remidex Pharma Private Limited on March 30, 2026.
The acquisition was executed under a Share Purchase Agreement first disclosed to exchanges on March 13, 2026.
Filing made under Regulation 30 of SEBI LODR, 2015; financial terms were disclosed in the earlier March 13 intimation.